ImportRefusal LogoImportRefusal

Glaxo Smith Kline UK

⚠️ High Risk

FEI: 3000263379 • Greenford • UNITED KINGDOM

FEI

FEI Number

3000263379

📍

Location

Greenford

🇬🇧
🏢

Address

889 Greenford Road, , Greenford, , United Kingdom

High Risk

FDA Import Risk Assessment

50.2
LowModerateHighCritical

This firm has a significant history of FDA import refusals with notable violations.

Statistics

15
Total Refusals
3
Unique Violations
11/6/2013
Latest Refusal
4/29/2008
Earliest Refusal

Score Breakdown

Violation Severity
85.3×40%
Refusal Volume
44.6×30%
Recency
0.0×20%
Frequency
27.1×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

7515×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

Refusal History

DateProductViolationsDivision
11/6/2013
66VIY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Philadelphia District Office (PHI-DO)
11/6/2013
66VIY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Philadelphia District Office (PHI-DO)
11/6/2013
66VIY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Philadelphia District Office (PHI-DO)
11/6/2013
66VIY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Philadelphia District Office (PHI-DO)
10/22/2013
66VIY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Philadelphia District Office (PHI-DO)
10/22/2013
66VIY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Philadelphia District Office (PHI-DO)
10/22/2013
66VIY99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
Philadelphia District Office (PHI-DO)
10/2/2013
64LAJ67CLOBETASOL PROPIONATE (GLUCOCORTICOID)
118NOT LISTED
3280FRNMFGREG
75UNAPPROVED
Los Angeles District Office (LOS-DO)
6/20/2012
64LCO03BETAMETHASONE (GLUCOCORTICOID)
75UNAPPROVED
New Orleans District Office (NOL-DO)
6/20/2012
64LCO67CLOBETASOL PROPIONATE (GLUCOCORTICOID)
75UNAPPROVED
New Orleans District Office (NOL-DO)
1/7/2012
64LDO67CLOBETASOL PROPIONATE (GLUCOCORTICOID)
75UNAPPROVED
New Orleans District Office (NOL-DO)
3/10/2011
63BCY25FLUTICASONE PROPIONATE (BRONCHODILATOR)
75UNAPPROVED
New Orleans District Office (NOL-DO)
1/6/2009
66VIP99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
New Orleans District Office (NOL-DO)
1/6/2009
66VIP99MISCELLANEOUS PATENT MEDICINES, ETC.
75UNAPPROVED
New Orleans District Office (NOL-DO)
4/29/2008
64LCJ67CLOBETASOL PROPIONATE (GLUCOCORTICOID)
75UNAPPROVED
Southwest Import District Office (SWI-DO)

Frequently Asked Questions

What is Glaxo Smith Kline UK's FDA import refusal history?

Glaxo Smith Kline UK (FEI: 3000263379) has 15 FDA import refusal record(s) in our database, spanning from 4/29/2008 to 11/6/2013.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Glaxo Smith Kline UK's FEI number is 3000263379.

What types of violations has Glaxo Smith Kline UK received?

Glaxo Smith Kline UK has been cited for 3 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Glaxo Smith Kline UK come from?

All FDA import refusal data for Glaxo Smith Kline UK is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.